Apollomics, Inc.

NASDAQ:APLM

Biotechnology

Healthcare
$17.84 +34.72%

+$6.03 today

Market cap
$52.00M
Beta
1.45
P/E (TTM)
-3.1
EPS (TTM)
-$25.98
52W Low $3.66High $42.12

Volume 0.02M

Average 0.02M

APLM Sales of Investments

Cash received from selling or redeeming investments.

Apollomics, Inc.NASDAQ: APLM

Sales of Investments · Q4 FY2025 · quarter ended Dec 2025

Sales of investments outflow grows to $0

Q4 FY2025 sales of investments was $0, compared with $0 a year earlier.

Context

  • Sales of investments amounted to 0.0% of revenue in FY2025, down 2909.6 pp from a year earlier.
  • Sales of investments increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterDec 2025
$0— QoQ
Last fiscal yearDec 2025
$0-100.0% YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-100.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
0 USD
Year-over-year change
-100.0%

Sales of Investments vs competitors

How APLM compares with its peers on the latest reported figures

  • APLM's FY2025 sales of investments of $0 is the largest of the 2 companies compared; the peer median is $0.
  • Sales of investments amounts to 0.0% of revenue for APLM, versus a peer median of 0.0%.
APLM Competitors Peer median
Sales of Investments for APLM and competitors
Company Period LTM YoY 3-year CAGR% of revenue
APLMApollomics, Inc.FY2025$0 -100.0%—0.0%
ANLAdlai Nortye Ltd.LTM Jun 2024$0 —-61.4%0.0%
Peer median (excluding APLM) $0—-61.4%0.0%

Competitors are the stored peer set for APLM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(94.8M)(240.81M)(172.59M)(53.6M)(10.94M)
Depreciation & Amortization681K775K669K361K255K
Deferred Income Tax00000
Stock-Based Compensation8.12M3.58M12.69M10.93M(979K)
Change in Working Capital2.64M6.49M(3.57M)1.04M(380K)
Accounts Receivables00000
Inventory00000
Accounts Payables00000
Other Working Capital2.64M6.49M(3.57M)1.04M(380K)
Other Non-Cash Items40.04M187.14M119.6M12.53M1.67M
Operating Cash Flow(43.31M)(42.82M)(43.21M)(28.74M)(10.37M)
Capital Expenditures(7.55M)(367K)(6K)(24K)0
Acquisitions (Net)00000
Purchases of Investments(103.79M)0000
Sales of Investments71.95M29M20.49M5.76M0
Other Investing Activities(7.06M)420K884K246K218K
Investing Cash Flow(38.95M)29.05M21.37M5.98M218K
Debt Repayment(528K)(593K)24.04M661K3.73M
Common Stock Issued141K392K85K07K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(1.26M)(93K)(2.9M)(193K)(65K)
Financing Cash Flow(1.64M)(294K)21.23M468K3.68M
Effect of Forex Changes0002K(15K)
Net Change in Cash(83.91M)(14.07M)(619K)(22.29M)(6.49M)
Free Cash Flow(50.86M)(43.19M)(43.22M)(28.77M)(10.37M)

Apollomics, Inc.

NASDAQ:APLM

Intrinsic Alpha fair value

Locked

Current Price

$17.84

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.